Skip to content

Insulin Resistance in Atopic Dermatitis Patients

The Relationship Between Insulin Resistance and Disease Severity and Duration in Atopic Dermatitis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05904509
Enrollment
32
Registered
2023-06-15
Start date
2022-09-01
Completion date
2023-10-01
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Keywords

atopic dermatitis, insulin resistance

Brief summary

The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis.

Detailed description

The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis. EASI and SCORAD values and disease duration of atopic dermatitis patients are calculated during the examination. HOMA-IR blood test result is compared with the results.

Interventions

None listed

Sponsors

Bezmialem Vakif University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Atopic dermatitis patients confirmed by a dermatologist

Exclusion criteria

* patients younger than 2 years * patients older than 80 years * Atopic dermatitis patients without HOMA-IR result

Design outcomes

Primary

MeasureTime frameDescription
HOMA-IR12 monthsPatients' blood test show the result of fasting insulin (microU/L) x fasting glucose (mmol/L)/22.5
SCORAD index12 monthsSeverity scoring of atopic dermatitis is calculated for each patient in the study. 6 intensity items (erythema, edema/papulation, oozing/crusts, excoriations, lichenification, dryness); 2 subjective symptoms(itch, sleeplessness); body surface area are studied. Max score is 103.
EASI index12 monthsEczema Area and Severity Index is calculated for each patient in the study. Body surface area, 4 intensity items(erythema, induration, excoriation, lichenification) are studied. Max score is 72.
Duration of the disease12 monthsThe time from the first onset of symptoms of the disease to the present. The relationship between insulin resistance and disease duration is examined

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026